Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Hearing aid group Sonova buys AudioNova in $953 million deal

Published 04/05/2016, 11:35
Updated 04/05/2016, 11:40
Hearing aid group Sonova buys AudioNova in $953 million deal
CSGN
-
DEMANT
-
SOON
-

ZURICH (Reuters) - Swiss hearing aid maker Sonova (S:SOON) is buying Dutch-based AudioNova for 830 million euros (658.87 million pound), its largest acquisition, to expand a network of European stores where it will jettison rivals' products in favour of its own.

The cash deal to buy AudioNova from Curacao-based investment company HAL Holding N.V. will add 1,300 stores in eight countries. That more than doubles Sonova's presence in Europe and boosts its worldwide store total to more than 3,300.

AudioNova now sells more than 300,000 hearing aids a year from different providers in eight European countries. Sonova products -- its brands include Unitron and Phonak -- account for about 25 percent of that figure.

Over the next two years, however, Sonova Chief Executive Lukas Braunschweiler said he plans to boost Sonova's share of AudioNova's sales to about 95 percent.

It is not uncommon for hearing aid retailers to switch between brands, Braunschweiler said, so he did not fear a customer backlash by swapping out rival products.

"Usually we bring share of wallet in our own retail chains up to about 95 percent of own products, that's the rule after two years, and we have about 5 percent other products left," he said.

AudioNova is expected to generate 2016 sales of approximately 360 million euros and an EBITDA margin of around 16 percent, Sonova said, adding the acquisition will lift earnings per share starting in the financial year 2017/2018.

Sonova shares rose more than 3 percent in early business, boosting their rise to 4.2 percent this year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bank Vontobel analyst Carla Baenziger said the transaction will give Sonova "critical size" in the retail market and is likely to be a blow to rival William Demant Holding (WDH) (CO:WDH), which has supplied AudioNova with hearing aids.

"The takeover is certainly bad news for WDH on volumes," she wrote in a note to investors.

William Demant has been buying retailers, too, including a move last year in France to snap up Audika. Demant did not immediately respond to an email seeking comment on Wednesday.

Sonova lifted sales last year by 4 percent to just over 2 billion Swiss francs ($2.09 billion).

Braunschweiler said Sonova won an auction run by ABN Amro, which advised HAL Holding, in which there were six bidders in the final stages, including three financial bidders and three strategic investors, including Sonova.

"It was a competitive race," said Braunschweiler, whose company's advisory team included Credit Suisse (S:CSGN).

Sonova will finance the deal, which is expected to close in the second half of this year, with cash and debt. It suspended a share buyback programme.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.